NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Reserve excluding Revaluation Reserve History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Reserve excluding Revaluation Reserve | ₹326 Cr | ₹279 Cr | ₹260 Cr | ₹219 Cr | ₹200 Cr |
What is the latest Reserve excluding Revaluation Reserve ratio of NGL FINECHEM ?
| Year | Reserve excluding Revaluation Reserve |
|---|---|
| Mar2026 | ₹326 Cr |
| Mar2025 | ₹279 Cr |
| Mar2024 | ₹260 Cr |
| Mar2023 | ₹219 Cr |
| Mar2022 | ₹200 Cr |
How is Reserve excluding Revaluation Reserve of NGL FINECHEM Trending?
| Years | Reserve excluding Revaluation Reserve | % Change | |
|---|---|---|---|
| Mar2026 | ₹326 Cr | 16.75 | |
| Mar2025 | ₹279 Cr | 7.63 | |
| Mar2024 | ₹260 Cr | 18.26 | |
| Mar2023 | ₹219 Cr | 9.66 | |
| Mar2022 | ₹200 Cr | - | |
Compare Reserve excluding Revaluation Reserve of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,866.0 Cr | 10.2% | 11.9% | 103.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,572.0 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 10.2% |
11.9% |
103.8% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses